Aripiprazole for Drug-Naive or Antipsychotic-Short-Exposure Subjects With Ultra-High Risk State and First-Episode Psychosis | Zendy

ChenChung Liu | Zendy; YiLing Chien | Zendy; Ming H. Hsieh | Zendy; TzungJeng Hwang | Zendy; HaiGwo Hwu | Zendy; ChihMin Liu | Zendy

Open Access

Aripiprazole for Drug-Naive or Antipsychotic-Short-Exposure Subjects With Ultra-High Risk State and First-Episode Psychosis

Author(s) -

ChenChung Liu,

YiLing Chien,

Ming H. Hsieh,

TzungJeng Hwang,

HaiGwo Hwu,

ChihMin Liu

Publication year - 2012

Publication title -

journal of clinical psychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.786

H-Index - 121

eISSN - 1533-712X

pISSN - 0271-0749

DOI - 10.1097/jcp.0b013e31827cb017

Subject(s) - aripiprazole , tolerability , positive and negative syndrome scale , antipsychotic , medicine , adverse effect , psychosis , psychopathology , schizophrenia (object oriented programming) , drug naïve , psychiatry , drug

This study aimed to observe treatment response using aripiprazole for subjects with ultra-high risk (UHR) state of psychosis or at their first-episode psychosis (FEP) who were drug-naive or only have received antipsychotic therapy temporarily.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research